ESR1 and breast cancer: In this study, we used two breast cancer cell lines MCF-7 cells (rapidly growing tumor cells that are ER-positive, E-cadherin positive and noninvasive15 and MDA-MB-231 (invasive and metastatic tumor cells) that are ER-negative and lacks E-cadherin16.